Thursday, October 20, 2016 10:01:59 AM
Before the opening bell, NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of communication solutions for business, announced the online availability of an interview with Bill Korn, chief financial officer of Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP). During the interview, Korn joined NNW’s Stuart Smith to discuss MTBC’s operations, recent achievements and the company’s ongoing execution of an acquisition-based growth strategy in order to maintain a competitive edge in the sizable healthcare IT market.
“MTBC has two cores strengths that distinguish us from most of the 1,500 other healthcare IT companies,” Korn explained in the interview. “We have an integrated cloud-based technology platform, which we developed in-house, and we have wholly owned offshore subsidiaries with 1,600 employees in four countries, with labor costs that average about 10% of the labor costs in the U.S. This allows us to provide services which are labor intensive even though we use our technology, and we can deliver these services much less expensively than our customers or competitors can provide them.”
To hear the full interview, visit http://nnw.fm/mtbc-interview-oct-2016
Thus far in 2016, MTBC has successfully achieved a number of milestones. The company has recorded three quarters of positive EBITDA since its IPO in 2014; raised $7.5 million of non-convertible stock on the NASDAQ; and, earlier this month, closed on the acquisition of MediGain, LLC and its Millennium Practice Management, LLC affiliate, marking MTBC’s largest acquisition to-date. The MediGain acquisition was not only completed at “a significant discount as compared to the industry norm,” according to Korn, it is also expected to play a major role in MTBC’s efforts to promote financial growth in the coming months, with the company’s CFO predicting that the acquisition “should be accretive to… shareholders in 2017.”
“We believe that our newly acquired business will contribute to our positive adjusted EBITDA by the first quarter of 2017,” Korn concluded. “By growing our overall revenue greatly through this acquisition, MTBC expects to generate significant operating leverage.”
For more information, visit www.MTBC.com
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM